According to the recent research report titled ‘Global Sepsis Diagnostics Market 2021-2028’, available with Market Study Report, global sepsis diagnostics market is projected to expand with a CAGR of 8.18%over 2021-2028.
 

Increasing prevalence of sepsis and growing number of hospital-acquired infections among patients are fueling global sepsis diagnostics market growth. Besides, rising number of government initiatives for research activities related to sepsis are significantly contributing to the market development.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3754652/
 

Considering restraints, hefty cost associated with instruments and reimbursement issues are likely to hamper the remuneration scope of the industry.
 

Based on technology, the market is split into molecular diagnostics, immunoassay, microbiology, and others. As per diagnostic method, the industry segmentation comprises automated diagnostics and conventional diagnostics. Moving on to product gamut, the market is bifurcated into instruments, assay kits & reagents, and blood culture media.
 

With respect to pathogen category, worldwide sepsis diagnostics industry is categorized into fungal sepsis, gram- positive and gram- negative bacterial sepsis, and others. Speaking of testing type, the industry is classified into point-of-care testing and laboratory testing.  
 

Elaborating on regional landscape, Latin America, Asia Pacific, Europe, North America are the top contributors to the overall market remuneration. Of these, Asia Pacific industry is projected to amass notable returns by the year 2028, owing to advancements in medical facilities in emerging economies like India and China, along with rapid economic development.
 

Furthermore, demand for sepsis diagnostics is likely to increase in APAC due to the high mortality rate linked with the disease. Growing awareness of sepsis detection and treatment is also expected to mitigate the disease's negative effects, further positively swaying the industry dynamics.
 

Major contenders impacting global sepsis diagnostics market trends are Thermo Fisher Scientific Inc., T2 Biosystems Inc., Response Biomedical Corporation, Luminex Corporation, Immunexpress Inc., F. Hoffmann-La Roche AG, EKF Diagnostics Holdings Plc, Danaher Corporation, CytoSorbents Corporation, Bruker Corporation, BioMérieux SA, Becton, Dickinson and Company (CR Bard), and Abbott Laboratories.
 

The research literature highlights the key strategies employed by industry contenders, along with recent developments such as product launches, acquisitions & mergers, and expansion roadmaps to assist stakeholders in gaining a competitive edge. Further, it factors in the impact of the Covid-19 pandemic for a stronger realization of the industry trends in the upcoming years.